✦ LIBER ✦

703 PUBLICATION Phase II multicenter study of capecitabine plus oxaliplatin (XELOX) sequentially followed by capecitabine and irinotecan (XELIRI) in first-line therapy for metastatic colorectal cancer (MCRC)

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of capecitabine plus oxal

✍ Yu Hong Li; Hui Yan Luo; Feng Hua Wang; Zhi Qiang Wang; Miao Zhen Qiu; Yan Xia S 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 234 KB

3051 POSTER Phase II trial of sequential

✍ S. Cupini; S. Bursi; G. Masi; F. Loupakis; C. Barbara; L. Fornaro; G. Allegrini; 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Capecitabine in combination with oxalipl

✍ Twelves, C.; Butts, C.; Cassidy, J.; Conroy, Th.; DeBraud, F.; Díaz-Rubio, E.; F 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 170 KB

698 PUBLICATION Efficacy and safety find

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 128 KB

6096 POSTER FOLFOXIRI (Irinotecan, Oxali

✍ Fornaro, L.; Loupakis, F.; Lonardi, S.; Masi, G.; Salvatore, L.; Cremolini, C.; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 49 KB